UASt regulatory sequences drive expression of an inverted repeat.
Scer\GAL4Dot.PK-mediated expression of snsGD65 completely abolishes the normal accumulation of ANF-RFP (expressed via Rnor\ANFMhc.T:Disc\RFP) in pericardial nephrocytes. EM analyses of mutant pericardial nephrocytes reveals reduced numbers of endocytic vesicles, shortened lacuna structures, and abolished nephrocyte diaphragms.
Co-expression of snsGD65 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4A3.eya results in a male-sterile phenotype, characterised by spermatogenic arrest at the elongated cyst stage and empty seminal vesicles.
Expression under the control of Scer\GAL4Mef2.PR results in late pupal lethality.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 30-40% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 60-70% of the Scer\GAL4pnr-MD237-expressing area of the notum.
The numbers of nephrocyte diaphragms in the garland cell nephrocytes of second instar larvae expressing snsGD65 under the control of Scer\GAL4sns.GCN is reduced compared to controls, although the NDs that do form appear normal by TEM analysis.
The surface of the garland cell nephrocytes of third instar larvae expressing snsGD65 under the control of Scer\GAL4sns.GCN is more uniform than that of control cells when analysed by SEM.
Garland cell nephrocytes from second instar larvae expressing snsGD65 under the control of Scer\GAL4sns.GCN show reduced uptake of both dextran 10kD and Alexa Fluor 555 BSA compared to controls after co-incubation with both tracers for 30 seconds.
Garland cell nephrocytes from second instar larvae expressing snsGD65 under the control of Scer\GAL4sns.GCN show efficient uptake of dextran 10kD after co-incubation with both Cascade Blue dextran 10kD and fluorescein dextran 500kD for 5 minutes. However, these cells show a very poor uptake of dextran 500kD under these conditions compared to controls.
Dcr-2UAS.cDa, Scer\GAL4GMR.PF, Scer\GAL4ey.PH, snsGD65 has eye phenotype
Scer\GAL4pnr-MD237, snsGD65 has thorax phenotype
Coexpression of Dcr-2Scer\UAS.cDa with snsGD65 under the control of Scer\GAL4ey.PH and Scer\GAL4GMR.PF causes an eye phenotype not seen when only snsGD2561 is expressed. Coexpression of the transgenes under the control of Scer\GAL4pnr-MD237 causes a defective thorax closure phenotype.